Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia
Apply
Ruxolitinib, Cladribine, Venetoclax
Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step